Eylea injection contain Aflibercept .
Eylea is marketed Bayer.
Eylea is indicated for The ‘wet’ form of age-related macular degeneration (AMD), a disease which affects the central part of the retina (called the macula) at the back of the eye.
1) Impaired vision due to macular oedema (swelling)
2) Impaired vision due to macular oedema associated with damage to blood vessels caused by diabetes.
Eylea is an anti-angiogenic which inhibit VEGF-A And VEGF-B and prevent the formation of New blood Vessels.
Eylea should be given to the patient und by the Opthalmologist only.
K M Healthcare is supplier of Eylea injection.